10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2010 | |||
Consolidated Statements of Income | |||
Period Ending Dec 31, 2010 10-K (Filed: Feb 25, 2011) | |||
| (In Millions) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | |
| Revenues: | |||
| Product sales | $ 14,660 | 14,351 | 14,687 |
| Other revenues | 393 | 291 | 316 |
| Total revenues | 15,053 | 14,642 | 15,003 |
| Operating expenses: | |||
| Cost of sales (excludes amortization of certain acquired intangible assets presented below) | 2,220 | 2,091 | 2,296 |
| Research and development | 2,894 | 2,864 | 3,030 |
| Selling, general and administrative | 3,983 | 3,820 | 3,789 |
| Amortization of certain acquired intangible assets | 294 | 294 | 294 |
| Other charges | 117 | 67 | 380 |
| Total operating expenses | 9,508 | 9,136 | 9,789 |
| Operating income | 5,545 | 5,506 | 5,214 |
| Interest expense, net | 604 | 578 | 551 |
| Interest and other income, net | 376 | 276 | 352 |
| Income before income taxes | 5,317 | 5,204 | 5,015 |
| Provision for income taxes | 690 | 599 | 963 |
| Net income | 4,627 | 4,605 | 4,052 |
| Earnings per share: | |||
| Basic | 4.82 | 4.53 | 3.79 |
| Diluted | 4.79 | 4.51 | 3.77 |
| Shares used in calculation of earnings per share: | |||
| Basic | 960 | 1,016 | 1,070 |
| Diluted | 965 | 1,021 | 1,075 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2010 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2010 10-K (Filed: Feb 25, 2011) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | |
| Cash flows from operating activities: | |||
| Net income | $ 4,627 | 4,605 | 4,052 |
| Depreciation and amortization | 1,017 | 1,049 | 1,073 |
| Stock-based compensation expense | 353 | 284 | 262 |
| Deferred income taxes | (167) | 47 | (137) |
| Property, plant and equipment impairments | 118 | 21 | 59 |
| Dividend received from equity investee | 0 | 110 | 8 |
| Other items, net | 140 | 111 | 244 |
| Changes in operating assets and liabilities, net of acquisitions: | |||
| Trade receivables, net | (210) | (36) | 65 |
| Inventories | 153 | (134) | (59) |
| Other current assets | 36 | (3) | 15 |
| Accounts payable | 142 | 71 | 95 |
| Accrued income taxes | (656) | (142) | 14 |
| Other accrued liabilities | 152 | 320 | (30) |
| Deferred revenue | 82 | 33 | 327 |
| Net cash provided by operating activities | 5,787 | 6,336 | 5,988 |
| Cash flows from investing activities: | |||
| Purchases of property, plant and equipment | (580) | (530) | (672) |
| Cash paid for acquisitions, net of cash acquired | 0 | 0 | (56) |
| Purchases of marketable securities | (14,602) | (12,418) | (10,345) |
| Proceeds from sales of marketable securities | 10,485 | 8,252 | 6,762 |
| Proceeds from maturities of marketable securities | 642 | 1,443 | 1,018 |
| Other | (97) | 51 | 128 |
| Net cash used in investing activities | (4,152) | (3,202) | (3,165) |
| Cash flows from financing activities: | |||
| Repurchases of common stock | (3,786) | (3,208) | (2,268) |
| Repayment of debt | 0 | (1,000) | (2,000) |
| Net proceeds from issuance of debt | 2,471 | 1,980 | 991 |
| Net proceeds from issuance of common stock in connection with the Company's equity award programs | 80 | 171 | 155 |
| Other | 3 | 33 | 49 |
| Net cash used in financing activities | (1,232) | (2,024) | (3,073) |
| Increase (decrease) in cash and cash equivalents | 403 | 1,110 | (250) |
| Cash and cash equivalents at beginning of period | 2,884 | 1,774 | |
| Cash and cash equivalents at end of period | 3,287 | 2,884 | 1,774 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
AMGEN INC | ||
Ticker: AMGN Fiscal Year: 2010 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2010 10-K (Filed: Feb 25, 2011) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2010 | Dec 31, 2009 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $ 3,287 | 2,884 |
| Marketable securities | 14,135 | 10,558 |
| Trade receivables, net | 2,335 | 2,109 |
| Inventories | 2,022 | 2,220 |
| Other current assets | 1,350 | 1,161 |
| Total current assets | 23,129 | 18,932 |
| Property, plant and equipment, net | 5,522 | 5,738 |
| Intangible assets, net | 2,230 | 2,567 |
| Goodwill | 11,334 | 11,335 |
| Other assets | 1,271 | 1,057 |
| Total assets | 43,486 | 39,629 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| Current liabilities: | ||
| Accounts payable | 716 | 574 |
| Accrued liabilities | 3,366 | 3,299 |
| Current portion of convertible notes | 2,488 | 0 |
| Total current liabilities | 6,570 | 3,873 |
| Convertible notes | 2,296 | 4,512 |
| Other long-term debt | 8,578 | 6,089 |
| Other non-current liabilities | 2,098 | 2,488 |
| Contingencies and commitments | ||
| Stockholders' equity: | ||
| Common stock and additional paid-in capital; $0.0001 par value; 2,750 shares authorized; outstanding - 932 shares in 2010 and 995 shares in 2009 | 27,299 | 26,944 |
| Accumulated deficit | (3,508) | (4,322) |
| Accumulated other comprehensive income | 153 | 45 |
| Total stockholders' equity | 23,944 | 22,667 |
| Total liabilities and stockholders' equity | 43,486 | 39,629 |
| External Links | |
| AMGEN INC (AMGN) Fiscal Year 2010 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |